Quick Takeaways
- GREAT POINT PARTNERS LLC filed SCHEDULE 13G/A for OPTINOSE, INC. Common Stock, $0.001 par value per share (OPTN).
- Disclosed ownership: 8.5%.
- Date of event: 31 Dec 2024.
GREAT POINT PARTNERS LLC - 31 Dec 2024 SCHEDULE 13G/A Report for OPTINOSE, INC. Common Stock, $0.001 par value per share (OPTN)
- Filing Manager
- GREAT POINT PARTNERS LLC
- Reporting Manager
- Great Point Partners, LLC
- Symbol
- OPTN
- Shares outstanding
- 10,585,419 shares
- Disclosed Ownership
- 896,585 shares
- Ownership
- 8.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 16:37:52 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"GREAT POINT PARTNERS LLC disclosed 8.5% ownership in OPTINOSE, INC. Common Stock, $0.001 par value per share (OPTN) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 16:37.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Great Point Partners, LLC | 8.5% | 896,585 | 0 | 896,585 | /s/ Dr. Jeffrey R. Jay, M.D | Dr. Jeffrey R. Jay, M.D - Senior Managing Member | |
| Dr. Jeffrey R. Jay, M.D. | 8.5% | 896,585 | 0 | 896,585 | /s/ Dr. Jeffrey R. Jay, M.D | Dr. Jeffrey R. Jay, M.D | |
| Ms. Lillian Nordahl | 8.5% | 896,585 | 0 | 896,585 | /s/ Ms. Lillian Nordahl | Ms. Lillian Nordahl |